Cell-based assays are valuable tools in drug discovery as they deliver physiologically relevant data on drug effects. Cell-based assays are considered to be the most complex of all bioanalytical methods and choosing the right partner is a critical decision.
IBR Inc. has a longstanding experience in cell-based assays including primary cells, transformed cell lines and transfected reporter-gene cell systems. The expertise of the IBR Inc. scientists enables characterization of many different biological activities of your molecule, like cell growth, cell death, induction of immunologic effector functions, biomarker expression, induction or inhibition of signaling events as well as drug internalization. By combining cell-bases assays and drug / target binding assays IBR Inc. has the capability to provide a comprehensive assessment of the mode of action of your molecule.